Related Experiment Video
Updated: Jun 18, 2026
06:47
Microfluidics in Assessing Platelet Function
Published on: November 8, 2024
Novel and unexpected clearance mechanisms for cold platelets
Viktoria Rumjantseva1, Karin M Hoffmeister
1Division of Translational Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA.
Summary
Platelet refrigeration is impossible due to rapid clearance from circulation. Understanding these clearance mechanisms is key to developing methods for long-term platelet preservation for transfusion.
Area of Science:
- Hematology
- Immunology
- Cell Biology
Background:
- Platelet storage at room temperature is limited to 5 days due to bacterial growth and loss of function.
- Refrigeration of platelets is currently impossible, leading to their rapid removal from circulation.
Purpose of the Study:
- To review current knowledge on platelet removal mechanisms.
- To summarize existing data on refrigerated platelet function.
- To explore methods for long-term preservation of platelet concentrates.
Main Methods:
- Review of existing literature on platelet clearance and refrigeration.
- Analysis of mechanisms involving glycoprotein receptors and macrophage recognition.
- Examination of cellular changes in platelets upon prolonged refrigeration.
Main Results:
- Acute chilling (<4h) causes clustering of glycoprotein (GP) Ibalpha receptors, leading to recognition by hepatic macrophages via beta GlcNAc residues and rapid platelet clearance.
- Prolonged refrigeration exposes galactose residues, resulting in platelet removal by hepatocytes through asialoglycoprotein receptors.
Conclusions:
- Platelet clearance mechanisms are complex, involving distinct pathways for acute chilling and prolonged refrigeration.
- Understanding these mechanisms is crucial for developing strategies to overcome current limitations in platelet storage and preservation.
- Further research into novel preservation methods is needed to ensure long-term availability of functional platelets for transfusion.
Related Concept Videos
01:22Formation of the Platelet Plug
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
01:18Structure and Function of Platelets
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
01:16Clot Retraction and Fibrinolysis
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
01:20Extrinsic and Intrinsic Pathways of Hemostasis
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...